BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (Nasdaq: ARRY - News) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the 21^st Annual Piper Jaffray Healthcare Conference on December 1 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Event:		21st Annual Piper Jaffray Healthcare Conference
Presenter:		Robert E. Conway, Chief Executive Officer, Array BioPharma
Date:		Tuesday, December 1, 2009
Time:		12:30 p.m. Eastern time
Location:		The New York Palace, NYC
Webcast:		www.arraybiopharma.com

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory and metabolic diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.

Array BioPharma Inc.
Tricia Haugetom 303-386-1193
thaugeto@arraybiopharma.com